Literature DB >> 4462487

Selective carotid vasoconstriction by ergotamine as a relevant mechanism in its antimigraine action.

P R Saxena.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4462487

Source DB:  PubMed          Journal:  Arch Neurobiol (Madr)        ISSN: 0004-0576


× No keyword cloud information.
  5 in total

Review 1.  Chemical mediators of migraine: preclinical and clinical observations.

Authors:  Saurabh Gupta; Stephanie J Nahas; B Lee Peterlin
Journal:  Headache       Date:  2011-06       Impact factor: 5.887

2.  Responsiveness of isolated canine cerebral and peripheral arteries to ergotamine.

Authors:  E Müller-Schweinitzer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

3.  Correlation between pharmacokinetics and clinical effects of ergotamine in patients suffering from migraine.

Authors:  V Ala-Hurula
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

4.  Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors.

Authors:  C M Villalón; P De Vries; G Rabelo; D Centurión; A Sánchez-López; P Saxena
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

5.  Systemic availability of ergotamine tartrate after oral, rectal and intramuscular administration.

Authors:  V Ala-Hurula; V V Myllylä; P Arvela; J Heikkilä; N Kärki; E Hokkanen
Journal:  Eur J Clin Pharmacol       Date:  1979-02-19       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.